Senior Correspondent, London
Ben's Feed
Oct 28, 2015

GlaxoSmithKline beats forecasts as HIV drugs, flu vaccines shine

LONDON (Reuters) – GlaxoSmithKline reported better-than-expected earnings on Wednesday, helped by strong demand for HIV drugs and flu vaccines, which offset a further slide in sales of respiratory medicine, sending its shares 3 percent higher.

Profits were also boosted by tight cost control, resulting in what Bernstein analyst Tim Anderson described as “the first green shoots of margin recovery”.

Oct 28, 2015

HIV drugs and flu vaccines help GlaxoSmithKline beat forecasts

LONDON, Oct 28 (Reuters) – GlaxoSmithKline reported
better-than-expected quarterly earnings on Wednesday, helped by
strong demand for HIV drugs and flu vaccines, which offset a
continued slide in sales of respiratory medicine, sending its
share 4 percent higher.

Sales, in sterling terms, rose 9 percent to 6.13 billion
pounds ($9.4 billion) in the three months ended Sept. 30,
generating core earnings per share (EPS) down 18 percent at 23.0
pence.

Oct 27, 2015

GSK heart drug flops in study, shingles vaccine on track

LONDON (Reuters) – An experimental heart drug from GlaxoSmithKline failed to work as hoped in the first part of a large clinical trial, the company said on Tuesday, dealing a blow to its pipeline of new medicines.

Losmapimod was being assessed as a treatment to reduce the risk of further cardiovascular problems after heart attacks, but it failed to show the hoped-for benefits and GSK said the result did not support investment in a larger second part of the study.

Oct 27, 2015

GlaxoSmithKline heart drug flops in study, shingles vaccine on track

LONDON (Reuters) – An experimental heart drug from GlaxoSmithKline (GSK.L: Quote, Profile, Research) failed to work as hoped in the first part of a large clinical trial, the company said on Tuesday, dealing a blow to its pipeline of new medicines.

Losmapimod was being assessed as a treatment to reduce the risk of further cardiovascular problems after heart attacks, but it failed to show the hoped-for benefits and GSK said the result did not support investment in a larger second part of the study.

Oct 27, 2015

Old drug may help keep Alzheimer’s patients out of nursing homes

LONDON (Reuters) – A cheap off-patent drug that relieves some symptoms of Alzheimer’s disease may also help keep people at an advanced stage of the illness out of nursing homes, at least for a while.

Research published on Tuesday showed that withdrawing the commonly used drug donepezil in moderate-to-severe patients doubled their risk of moving into nursing care within a year, although it made no difference during the following three years.

Oct 23, 2015

World’s first malaria vaccine delayed as WHO experts urge caution

GENEVA/LONDON (Reuters) – The world’s first malaria vaccine is promising but should be used on a pilot basis before any wide-scale use, given its limited efficacy, World Health Organization (WHO) experts said on Friday.

The decision is likely to delay a possible broad roll-out of the shot for between three and five years.

Oct 23, 2015

WHO experts urge demo tests before wider use of malaria vaccine

GENEVA/LONDON, Oct 23 (Reuters) – The world’s first malaria
vaccine is promising but should be used on a pilot basis before
any wide-scale use, given its limited efficacy, World Health
Organization experts said on Friday.

The Mosquirix shot, made by GlaxoSmithKline, could
potentially help stop millions of cases of malaria in babies and
young children in Africa at risk of the deadly mosquito-borne
disease. However, it is less effective than vaccines against
many other diseases.

Oct 23, 2015

Amgen wins EU green light for first virus-based cancer drug

LONDON (Reuters) – A first-in-class drug from Amgen based on a tumour-killing virus was given a green light by European regulators on Friday, paving the way for its approval within a couple of months.

The decision is a further milestone for a technology that has long fascinated scientists but has previously proved difficult to harness.

Oct 22, 2015

Alzheimer’s takes centre stage as new plays tackle memory loss

LONDON, Oct 22 (Reuters) – Alzheimer’s disease is moving out
of the shadows as new plays tackle head-on the emotional pain of
a condition that robs its victims of words, memories and
coherent thought.

For a generation of young playwrights, dementia is proving
to be a touchstone issue as taboos around the condition fall
away and the disorder reaches into the lives of more and more
families worldwide.

Oct 21, 2015

Genetics help explain poor showing for GSK malaria vaccine

LONDON (Reuters) – Scientists have found a genetic explanation for why the world’s first malaria vaccine is not very effective in protecting some African children against the deadly mosquito-borne disease.

The analysis, published in the New England Journal of Medicine on Wednesday, comes at a critical time for the experimental shot from GlaxoSmithKline, when global experts are assessing how it might be deployed.

    • About Ben

      "Ben Hirschler is European pharmaceuticals, biotechnology and healthcare correspondent, based in London. Previously, he was in charge of British company news and before that was posted to Johannesburg, covering the economic challenges facing post-apartheid South Africa."
    • More from Ben

    • Follow Ben